- Numinus Wellness (NUMI) launches the Numinus Network, a new clinic licensing model
- The Numinus Network offers independent practitioners the ability to own and operate clinics under the Numinus Wellness brand
- The launch is designed to facilitate North American expansion while reducing capital investment
- Numinus is currently in discussions with several prospective clinic owners
- Founder and CEO, Payton Nyquvest, spoke with Simon Druker about the news
- Numinus Wellness develops and delivers innovative mental healthcare and access to safe, evidence-based psychedelic-assisted therapies
- Numinus Wellness (NUMI) last traded at $0.19 per share
Numinus Wellness (NUMI) launches the Numinus Network, a new clinic licensing model.
The Numinus Network offers independent practitioners the ability to own and operate clinics under the Numinus Wellness brand.
The launch is designed to bring Numinus’ expertise to new regions across North America with reduced capital investment.
Benefits include a proven clinic model, comprehensive training curriculum, access to Numinus treatment protocols, ongoing operational and marketing support, and access to Numinus’ network of healthcare professionals.
Numinus is currently in discussions with several prospective clinic owners.
“We believe that we are on the verge of a significant shift in mental healthcare as psychedelic-assisted therapy is becoming more accessible, and Numinus wants to take a leading role in providing this important clinical care,” stated Payton Nyquvest, Numinus’ Founder and CEO.
A new partnership with Healing Commercial Real Estate (CREI) – a healthcare-focused real estate investment company with deep market knowledge of the psychedelic sector – allows licensees to lease a fully functioning Numinus Wellness clinic location directly from Healing CREI.
Healing CREI will employ targeted planning to determine regions where the psychedelic, behavioral health, and wellness industry is lacking or underserved.
Nyquvest spoke with Simon Druker about the news.
Numinus Wellness develops and delivers innovative mental healthcare and access to safe, evidence-based psychedelic-assisted therapies.
Numinus Wellness (NUMI) last traded at $0.19 per share.
This is sponsored content, please see full disclaimer here.